{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:42:08Z","timestamp":1793191328833,"version":"4.5.0"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871709"],"award-info":[{"award-number":["81871709"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.cyto.2024.156770","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T08:23:30Z","timestamp":1727252610000},"page":"156770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Chemokines and chemokine receptors: Potential therapeutic targets in systemic lupus erythematosus"],"prefix":"10.1016","volume":"184","author":[{"given":"Lishuang","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2024.156770_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1100869","article-title":"Chemokines and chemokine receptors as promising targets in rheumatoid arthritis","volume":"14","author":"Murayama","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2024.156770_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1176619","article-title":"The chemokine landscape: one system multiple shades","volume":"14","author":"Cecchinato","year":"2023","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156770_b0015","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines and the immune response to cancer","volume":"54","author":"Ozga","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2024.156770_b0020","article-title":"Chemokines and chemokine receptors in Behcet's disease","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2024.156770_b0025","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.brainresbull.2021.05.024","article-title":"The progress of chemokines and chemokine receptors in autism spectrum disorders","volume":"174","author":"Ye","year":"2021","journal-title":"Brain Res. Bull."},{"issue":"11","key":"10.1016\/j.cyto.2024.156770_b0030","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1002\/cam4.3014","article-title":"Chemokines and chemokine receptors: a new strategy for breast cancer therapy","volume":"9","author":"Liu","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.cyto.2024.156770_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116040","article-title":"The functional roles of chemokines and chemokine receptors in colorectal cancer progression","volume":"170","author":"Yue","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.cyto.2024.156770_b0040","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1042\/BST20201114","article-title":"Latest update on chemokine receptors as therapeutic targets","volume":"49","author":"Lai","year":"2021","journal-title":"Biochem. Soc. Trans."},{"issue":"11","key":"10.1016\/j.cyto.2024.156770_b0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11912-021-01117-8","article-title":"Chemokine receptor antagonists: role in oncology","volume":"23","author":"Kraus","year":"2021","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.cyto.2024.156770_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156504","article-title":"Atypical chemokine receptors in cancer","volume":"176","author":"Samus","year":"2024","journal-title":"Cytokine"},{"issue":"12","key":"10.1016\/j.cyto.2024.156770_b0055","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.tips.2022.09.009","article-title":"Atypical chemokine receptors: emerging therapeutic targets in cancer","volume":"43","author":"Torphy","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.cyto.2024.156770_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/25785826.2019.1628466","article-title":"Systemic lupus erythematosus and immunodeficiency","volume":"42","author":"Sawada","year":"2019","journal-title":"Immunol. Med."},{"issue":"18","key":"10.1016\/j.cyto.2024.156770_b0065","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1097\/CM9.0000000000000983","article-title":"Systemic lupus erythematosus: year in review 2019","volume":"133","author":"Fan","year":"2020","journal-title":"Chin. Med. J .(Engl.)"},{"issue":"3","key":"10.1016\/j.cyto.2024.156770_b0070","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40744-020-00212-9","article-title":"Systemic Lupus Erythematosus (SLE) therapy: the old and the new","volume":"7","author":"Basta","year":"2020","journal-title":"Rheumatol Ther"},{"issue":"7","key":"10.1016\/j.cyto.2024.156770_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076578","article-title":"Advances in the pathogenesis and treatment of systemic lupus erythematosus","volume":"24","author":"Accapezzato","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cyto.2024.156770_b0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/cei.12380","article-title":"Pathogenetic role of glomerular CXCL13 expression in lupus nephritis","volume":"178","author":"Worthmann","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cyto.2024.156770_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.763065","article-title":"CXCL13 neutralization attenuates neuropsychiatric manifestations in lupus-prone mice","volume":"12","author":"Huang","year":"2021","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2024.156770_b0090","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1093\/rheumatology\/kead091","article-title":"Reduced homovanillic acid, SDF-1alpha and SCGF-beta levels in cerebrospinal fluid are related to depressive states in systemic lupus erythematosus","volume":"62","author":"Fujita","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl5","key":"10.1016\/j.cyto.2024.156770_b0095","doi-asserted-by":"crossref","first-page":"v12","DOI":"10.1093\/rheumatology\/keaa484","article-title":"New biomarkers in SLE: from bench to bedside","volume":"59","author":"Capecchi","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.cyto.2024.156770_b0100","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1177\/0961203320947805","article-title":"Soluble ST2 and CXCL-10 may serve as biomarkers of subclinical diastolic dysfunction in SLE and correlate with disease activity and damage","volume":"29","author":"Chorin","year":"2020","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.cyto.2024.156770_b0105","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.176556","article-title":"Impaired innate and adaptive immune responses to BNT162b2 SARS-CoV-2 vaccination in systemic lupus erythematosus","volume":"9","author":"Sarin","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.cyto.2024.156770_b0110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.matbio.2017.12.002","article-title":"Biglycan, a novel trigger of Th1 and Th17 cell recruitment into the kidney","volume":"68\u201369","author":"Nastase","year":"2018","journal-title":"Matrix Biol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156770_b0115","article-title":"A study of IFN-alpha-induced chemokines CCL2, CXCL10 and CCL19 in patients with systemic lupus erythematosu","volume":"12","author":"Geneva-Popova","year":"2022","journal-title":"Life (Basel)"},{"issue":"12","key":"10.1016\/j.cyto.2024.156770_b0120","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.4049\/jimmunol.1500961","article-title":"FLI1 levels impact CXCR3 expression and renal infiltration of T cells and renal glycosphingolipid metabolism in the MRL\/lpr lupus mouse strain","volume":"195","author":"Sundararaj","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2024.156770_b0125","doi-asserted-by":"crossref","first-page":"7096912","DOI":"10.1155\/2019\/7096912","article-title":"Tetramethylpyrazine prevents contrast-induced nephropathy via modulating tubular cell mitophagy and suppressing mitochondrial fragmentation, CCL2\/CCR2-mediated inflammation, and intestinal injury","volume":"2019","author":"Gong","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"9","key":"10.1016\/j.cyto.2024.156770_b0130","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1038\/s41418-021-00775-2","article-title":"CCL2 regulation of MST1-mTOR-STAT1 signaling axis controls BCR signaling and B-cell differentiation","volume":"28","author":"Yang","year":"2021","journal-title":"Cell Death Differ."},{"issue":"8","key":"10.1016\/j.cyto.2024.156770_b0135","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1177\/09612033221102076","article-title":"Identification of ferroptosis-related molecular markers in glomeruli and tubulointerstitium of lupus nephritis","volume":"31","author":"Wang","year":"2022","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.cyto.2024.156770_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041372","article-title":"The urinary exosomal miRNA expression profile is predictive of clinical response in lupus nephritis","volume":"21","author":"Garcia-Vives","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cyto.2024.156770_b0145","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00441-021-03473-0","article-title":"Regulation and function of CX3CR1 and its ligand CX3CL1 in kidney disease","volume":"385","author":"von Vietinghoff","year":"2021","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.cyto.2024.156770_b0150","article-title":"A double-edged sword: interactions of CX(3)CL1\/CX(3)CR1 and gut microbiota in systemic lupus erythematosus","volume":"14","author":"Estaleen","year":"2023","journal-title":"Front. Immunol."},{"issue":"16","key":"10.1016\/j.cyto.2024.156770_b0155","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J."},{"issue":"11","key":"10.1016\/j.cyto.2024.156770_b0160","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1161\/ATVBAHA.115.306359","article-title":"Chemokines","volume":"35","author":"van der Vorst","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cyto.2024.156770_b0165","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3389\/fimmu.2019.00333","article-title":"Chemokines modulate immune surveillance in tumorigenesis, metastasis, and response to immunotherapy","volume":"10","author":"Vilgelm","year":"2019","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156770_b0170","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1002\/mco2.147","article-title":"Role of chemokine systems in cancer and inflammatory diseases","volume":"3","author":"Li","year":"2022","journal-title":"MedComm (2020)"},{"issue":"6","key":"10.1016\/j.cyto.2024.156770_b0175","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/s43018-023-00553-8","article-title":"EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance","volume":"4","author":"Chibaya","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.cyto.2024.156770_b0180","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.3389\/fimmu.2020.02109","article-title":"The chemokine receptor CXCR4 in cell proliferation and tissue regeneration","volume":"11","author":"Bianchi","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156770_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021526","article-title":"Pathophysiology of inflammatory bowel disease: innate immune system","volume":"24","author":"Saez","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2024.156770_b0190","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fimmu.2020.00325","article-title":"Chemokine receptors and phagocyte biology in zebrafish","volume":"11","author":"Sommer","year":"2020","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156770_b0195","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.yexcr.2011.01.012","article-title":"Atypical chemokine receptors","volume":"317","author":"Ulvmar","year":"2011","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.cyto.2024.156770_b0200","doi-asserted-by":"crossref","first-page":"241","DOI":"10.15403\/jgld-4660","article-title":"Update on the role of chemokines and chemokine receptors in liver fibrosis","volume":"32","author":"Li","year":"2023","journal-title":"J. Gastrointestin. Liver Dis."},{"issue":"5","key":"10.1016\/j.cyto.2024.156770_b0205","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.immuni.2009.09.010","article-title":"Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology","volume":"31","author":"Ransohoff","year":"2009","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.cyto.2024.156770_b0210","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/BOR.0000000000000922","article-title":"An update on autoantibodies in systemic lupus erythematosus","volume":"35","author":"Gomez-Banuelos","year":"2023","journal-title":"Curr. Opin. Rheumatol."},{"issue":"10","key":"10.1016\/j.cyto.2024.156770_b0215","first-page":"e30330","article-title":"An Overview of Systemic Lupus Erythematosus (SLE) pathogenesis, classification, and management","volume":"14","author":"Ameer","year":"2022","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.cyto.2024.156770_b0220","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/annrheumdis-2018-214502","article-title":"Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity","volume":"78","author":"Jesus","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2024.156770_b0225","doi-asserted-by":"crossref","first-page":"1011591","DOI":"10.3389\/fimmu.2022.1011591","article-title":"SLE classification criteria: Science-based icons or algorithmic distractions - an intellectually demanding dilemma","volume":"13","author":"Rekvig","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2024.156770_b0230","doi-asserted-by":"crossref","unstructured":"M. Koo, M.C. Lu, Performance of a new instrument for the measurement of systemic lupus erythematosus disease activity: the SLE-DAS, Medicina (Kaunas) 59(12) (2023).","DOI":"10.3390\/medicina59122097"},{"issue":"3","key":"10.1016\/j.cyto.2024.156770_b0235","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11926-021-00984-1","article-title":"A review of complement activation in SLE","volume":"23","author":"Weinstein","year":"2021","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.cyto.2024.156770_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102976","article-title":"T follicular helper cells in autoimmune diseases","volume":"134","author":"Wei","year":"2023","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.cyto.2024.156770_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103262","article-title":"Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus","volume":"22","author":"Erazo-Martinez","year":"2023","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.cyto.2024.156770_b0250","doi-asserted-by":"crossref","first-page":"429","DOI":"10.21037\/atm-20-5232","article-title":"Role of biomarkers in the diagnosis and prognosis of patients with cutaneous lupus erythematosus","volume":"9","author":"Zhu","year":"2021","journal-title":"Ann. Transl. Med."},{"issue":"3","key":"10.1016\/j.cyto.2024.156770_b0255","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.abd.2022.09.005","article-title":"Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects","volume":"98","author":"Vale","year":"2023","journal-title":"An. Bras. Dermatol."},{"issue":"9","key":"10.1016\/j.cyto.2024.156770_b0260","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41584-019-0272-0","article-title":"Cutaneous lupus erythematosus: new insights into pathogenesis and therapeutic strategies","volume":"15","author":"Wenzel","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156770_b0265","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/jid.2010.244","article-title":"Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFNlambda) in cutaneous lupus erythematosus","volume":"131","author":"Zahn","year":"2011","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.cyto.2024.156770_b0270","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/path.1721","article-title":"Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus","volume":"205","author":"Wenzel","year":"2005","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156770_b0275","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00403-008-0892-8","article-title":"Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus","volume":"301","author":"Wenzel","year":"2009","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.cyto.2024.156770_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102871","article-title":"Lupus nephritis: new progress in diagnosis and treatment","volume":"132","author":"Yu","year":"2022","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.cyto.2024.156770_b0285","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/j.ajkd.2019.10.017","article-title":"Update on lupus nephritis: core curriculum 2020","volume":"76","author":"Parikh","year":"2020","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"10.1016\/j.cyto.2024.156770_b0290","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.cyto.2024.156770_b0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000511268","article-title":"Update on lupus nephritis: looking for a new vision","volume":"145","author":"Morales","year":"2021","journal-title":"Nephron"},{"issue":"7","key":"10.1016\/j.cyto.2024.156770_b0300","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073766","article-title":"Advances in lupus nephritis pathogenesis: from bench to bedside","volume":"22","author":"Obrisca","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cyto.2024.156770_b0305","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000870","article-title":"Transcription factor Fli-1 impacts the expression of CXCL13 and regulates immune cell infiltration into the kidney in MRL\/lpr mouse","volume":"10","author":"Sato","year":"2023","journal-title":"Lupus Sci. Med."},{"issue":"4","key":"10.1016\/j.cyto.2024.156770_b0310","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10238-021-00707-x","article-title":"The CXCL13 chemokine serves as a potential biomarker to diagnose systemic lupus erythematosus with disease activity","volume":"21","author":"Zeng","year":"2021","journal-title":"Clin. Exp. Med."},{"issue":"5","key":"10.1016\/j.cyto.2024.156770_b0315","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41419-024-06708-4","article-title":"Macrophages communicate with mesangial cells through the CXCL12\/DPP4 axis in lupus nephritis pathogenesis","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.cyto.2024.156770_b0320","doi-asserted-by":"crossref","first-page":"e2250319","DOI":"10.1002\/eji.202250319","article-title":"Persistently active interferon-gamma pathway and expansion of T-bet(+) B cells in a subset of patients with childhood-onset systemic lupus erythematosus","volume":"53","author":"Moneta","year":"2023","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2024.156770_b0325","doi-asserted-by":"crossref","first-page":"1303076","DOI":"10.3389\/fimmu.2023.1303076","article-title":"Role of MCP-1 as an inflammatory biomarker in nephropathy","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156770_b0330","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1097\/01.ASN.0000130082.67775.60","article-title":"Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice","volume":"15","author":"Anders","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.cyto.2024.156770_b0335","doi-asserted-by":"crossref","first-page":"886","DOI":"10.4049\/jimmunol.1300123","article-title":"CCR1 inhibition ameliorates the progression of lupus nephritis in NZB\/W mice","volume":"192","author":"Bignon","year":"2014","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156770_b0340","doi-asserted-by":"crossref","first-page":"2224890","DOI":"10.1080\/0886022X.2023.2224890","article-title":"Expression of interferon-stimulated gene 20 (ISG20), an antiviral effector protein, in glomerular endothelial cells: possible involvement of ISG20 in lupus nephritis","volume":"45","author":"Karasawa","year":"2023","journal-title":"Ren. Fail."},{"issue":"3","key":"10.1016\/j.cyto.2024.156770_b0345","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2478\/rir-2021-0022","article-title":"Cardiovascular disease in systemic lupus erythematosus","volume":"2","author":"McMahon","year":"2021","journal-title":"Rheumatol. Immunol. Res."},{"issue":"3","key":"10.1016\/j.cyto.2024.156770_b0350","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00281-022-00922-y","article-title":"Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus","volume":"44","author":"Oliveira","year":"2022","journal-title":"Semin. Immunopathol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156770_b0355","first-page":"e22027","article-title":"Systemic lupus erythematosus and cardiovascular disease","volume":"14","author":"Jha","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.cyto.2024.156770_b0360","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaut.2015.07.001","article-title":"CD4+CXCR3+ T cells and plasmacytoid dendritic cells drive accelerated atherosclerosis associated with systemic lupus erythematosus","volume":"63","author":"Clement","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cyto.2024.156770_b0365","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41232-020-00118-7","article-title":"Emerging roles of Toll-like receptor 9 in cardiometabolic disorders","volume":"40","author":"Nishimoto","year":"2020","journal-title":"Inflamm. Regen."},{"issue":"5","key":"10.1016\/j.cyto.2024.156770_b0370","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00011-023-01731-1","article-title":"CX(3)CR1 modulates SLE-associated glomerulonephritis and cardiovascular disease in MRL\/lpr mice","volume":"72","author":"Cabana-Puig","year":"2023","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.cyto.2024.156770_b0375","doi-asserted-by":"crossref","first-page":"22341","DOI":"10.1038\/srep22341","article-title":"Vitamin D improves endothelial dysfunction and restores myeloid angiogenic cell function via reduced CXCL-10 expression in systemic lupus erythematosus","volume":"6","author":"Reynolds","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2024.156770_b0380","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijcard.2017.02.107","article-title":"Circulating microparticle subpopulations in systemic lupus erythematosus are affected by disease activity","volume":"236","author":"Lopez","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.cyto.2024.156770_b0385","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/268436","article-title":"Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus","volume":"2010","author":"Okamoto","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"issue":"9","key":"10.1016\/j.cyto.2024.156770_b0390","first-page":"e17969","article-title":"Neuropsychiatric systemic lupus erythematosus: a 2021 update on diagnosis, management, and current challenges","volume":"13","author":"Sarwar","year":"2021","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.cyto.2024.156770_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102780","article-title":"Neuropsychiatric involvement in systemic lupus erythematosus: a review","volume":"20","author":"Carrion-Barbera","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cyto.2024.156770_b0400","doi-asserted-by":"crossref","first-page":"1111769","DOI":"10.3389\/fneur.2023.1111769","article-title":"The conundrum of neuropsychiatric systemic lupus erythematosus: current and novel approaches to diagnosis","volume":"14","author":"Emerson","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.cyto.2024.156770_b0405","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.998328","article-title":"Pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus: a review","volume":"10","author":"Liu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"8","key":"10.1016\/j.cyto.2024.156770_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102592","article-title":"The immunologic etiology of psychiatric manifestations in systemic lupus erythematosus: a narrative review on the role of the blood brain barrier, antibodies, cytokines and chemokines","volume":"19","author":"Deijns","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.cyto.2024.156770_b0415","first-page":"212","article-title":"Central nervous system systemic lupus erythematosus: pathophysiologic","volume":"42","author":"Ota","year":"2022","journal-title":"Clin. Imag. Feat. Radiogr."},{"key":"10.1016\/j.cyto.2024.156770_b0420","doi-asserted-by":"crossref","first-page":"1157149","DOI":"10.3389\/fimmu.2023.1157149","article-title":"Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus","volume":"14","author":"Cocco","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156770_b0425","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12020192","article-title":"Biomarkers in neuropsychiatric systemic lupus erythematosus: a systematic literature review of the last decade","volume":"12","author":"Lindblom","year":"2022","journal-title":"Brain Sci."},{"issue":"2","key":"10.1016\/j.cyto.2024.156770_b0430","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.4049\/jimmunol.182.2.1192","article-title":"Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus","volume":"182","author":"Santer","year":"2009","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2024.156770_b0435","first-page":"16658","article-title":"Role of IL-1\u03b2, IL-6, IL-8 and IFN-\u03b3 in pathogenesis of central nervous system neuropsychiatric systemic lupus erythematous","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"9","key":"10.1016\/j.cyto.2024.156770_b0440","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1177\/0961203316629556","article-title":"IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus","volume":"25","author":"Yoshio","year":"2016","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.cyto.2024.156770_b0445","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard.2005.041640","article-title":"Raised monocyte chemotactic protein-1 (MCP-1)\/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus","volume":"65","author":"Iikuni","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2024.156770_b0450","article-title":"C-X-C motif chemokine 10 contributes to the development of neuropathic pain by increasing the permeability of the blood-spinal cord barrier","volume":"11","author":"Li","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2024.156770_b0455","doi-asserted-by":"crossref","first-page":"15150","DOI":"10.3390\/ijms160715150","article-title":"Behavioral deficits are accompanied by immunological and neurochemical changes in a mouse model for Neuropsychiatric Lupus (NP-SLE)","volume":"16","author":"Li","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2024.156770_b0460","doi-asserted-by":"crossref","first-page":"6012715","DOI":"10.1155\/2016\/6012715","article-title":"Chemokines and chemokine receptors in the development of lupus nephritis","volume":"2016","author":"Liao","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cyto.2024.156770_b0465","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/715190","article-title":"Immunopathological roles of cytokines, chemokines, signaling molecules, and pattern-recognition receptors in systemic lupus erythematosus","volume":"2012","author":"Yu","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"8","key":"10.1016\/j.cyto.2024.156770_b0470","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.acthis.2015.09.001","article-title":"CXCL13 blockade attenuates lupus nephritis of MRL\/lpr mice","volume":"117","author":"Wu","year":"2015","journal-title":"Acta Histochem."},{"key":"10.1016\/j.cyto.2024.156770_b0475","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clim.2016.07.003","article-title":"Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis","volume":"169","author":"Devarapu","year":"2016","journal-title":"Clin. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156770_b0480","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.4049\/jimmunol.170.6.3392","article-title":"Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis in murine lupus","volume":"170","author":"Balabanian","year":"2003","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156770_b0485","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/art.21007","article-title":"Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL\/lpr mice","volume":"52","author":"Inoue","year":"2005","journal-title":"Arthrit. Rheum."},{"issue":"6","key":"10.1016\/j.cyto.2024.156770_b0490","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/eji.201747023","article-title":"CXCR4-CXCL12 interaction is important for plasma cell homing and survival in NZB\/W mice","volume":"48","author":"Cheng","year":"2018","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2024.156770_b0495","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000330685","article-title":"Antiproteinuric effect of chemokine C-C motif ligand 2 inhibition in subjects with acute proliferative lupus nephritis","volume":"34","author":"Ble","year":"2011","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.cyto.2024.156770_b0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155640","article-title":"A review on the role of chemokines in the pathogenesis of systemic lupus erythematosus","volume":"146","author":"Ghafouri-Fard","year":"2021","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.cyto.2024.156770_b0505","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrrheum.2015.157","article-title":"Successes and failures of chemokine-pathway targeting in rheumatoid arthritis","volume":"12","author":"Szekanecz","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"issue":"20","key":"10.1016\/j.cyto.2024.156770_b0510","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.2174\/09298673113209990117","article-title":"Hetero-oligomerization of chemokine receptors: diversity and relevance for function","volume":"20","author":"Kraemer","year":"2013","journal-title":"Curr. Med. Chem."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624002746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624002746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T23:29:03Z","timestamp":1731972543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466624002746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":102,"alternative-id":["S1043466624002746"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156770","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemokines and chemokine receptors: Potential therapeutic targets in systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156770"}}